









Markets
/
Stocks
/
nasdaq-bcpc
/

Balchem Corp

BCPC

153.390USD

-0.580-0.38%

Close 10/31, 16:00（ET）Quotes delayed by 15 min

4.97BMarket Cap

33.28P/E TTM



Balchem Corp

153.390

-0.580-0.38%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Balchem Corp

Currency: USD Updated: 2025-10-31

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Balchem Corp's Score

Industry at a Glance

Industry Ranking

3 / 70

Overall Ranking

69 / 4618

Industry

Chemicals

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 2 analysts

Buy

Current Rating

200.667

Target Price

+30.82%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Balchem Corp Highlights

StrengthsRisks

Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company's segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. Through Specialty Products, it re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 953.68M.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 22.16%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 22.16%.

Undervalued

The company’s latest PB is 3.83, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 29.74M shares, decreasing 0.42% quarter-over-quarter.

Held by Wasatch Global Investors

Star Investor Wasatch Global Investors holds 960.09K shares of this stock.

Financial Health

Currency: USD Updated: 2025-10-31

The company's current financial score is 9.08, which is higher than the Chemicals industry's average of 7.35. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 267.56M, representing a year-over-year increase of 11.51%, while its net profit experienced a year-over-year increase of 19.07%.

Score

Industry at a Glance

Previous score

9.08

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

8.46

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

8.65

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

9.18

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

9.13

Key Metrics

Free cash flow

No Data

Balchem Corp's Company Valuation

Currency: USD Updated: 2025-10-31

The company’s current valuation score is 3.54, which is lower than the Chemicals industry's average of 7.47. Its current P/E ratio is 33.27, which is 50.49% below the recent high of 50.07 and 8.53% above the recent low of 30.43.

Score

Industry at a Glance

Previous score

3.54

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 3/70

No Data

Earnings Forecast

Currency: USD Updated: 2025-10-31

The company’s current earnings forecast score is 8.00, which is higher than the Chemicals industry's average of 7.26. The average price target for Balchem Corp is 192.00, with a high of 220.00 and a low of 190.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 2 analysts

Buy

Current Rating

200.667

Target Price

+30.82%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Balchem Corp

BCPC

Apple Inc

AAPL

GE Vernova Inc

GEV

Tapestry Inc

TPR

FMC Corp

FMC

Avantor Inc

AVTR

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-31

The company’s current price momentum score is 9.04, which is higher than the Chemicals industry's average of 6.68. Sideways: Currently, the stock price is trading between the resistance level at 161.77 and the support level at 142.09, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.10

Change

-0.06

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(3)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

1.640

Buy

RSI(14)

54.298

Neutral

STOCH(KDJ)(9,3,3)

61.495

Neutral

ATR(14)

3.857

High Vlolatility

CCI(14)

30.146

Neutral

Williams %R

30.083

Buy

TRIX(12,20)

0.153

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

154.142

Sell

MA10

154.885

Sell

MA20

149.141

Buy

MA50

153.322

Buy

MA100

155.834

Sell

MA200

159.914

Sell

Institutional Confidence

Currency: USD Updated: 2025-10-31

The company’s current institutional recognition score is 10.00, which is higher than the Chemicals industry's average of 6.91. The latest institutional shareholding proportion is 91.63%, representing a quarter-over-quarter decrease of 0.31%. The largest institutional shareholder is The Vanguard, holding a total of 3.89M shares, representing 12.01% of shares outstanding, with 1.25% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

4.44M

-2.45%

The Vanguard Group, Inc.

Star Investors

3.89M

+1.24%

Conestoga Capital Advisors, LLC

1.15M

-1.63%

State Street Investment Management (US)

1.23M

-0.12%

Geode Capital Management, L.L.C.

980.97K

+1.48%

Wasatch Global Investors Inc

Star Investors

960.09K

-10.19%

Geneva Capital Management LLC

895.53K

+7.79%

Dimensional Fund Advisors, L.P.

575.40K

-3.09%

Norges Bank Investment Management (NBIM)

469.08K

+8.97%

Fidelity Management & Research Company LLC

463.09K

+5.36%

Risk Assessment

Currency: USD Updated: 2025-10-31

The company’s current risk assessment score is 9.08, which is higher than the Chemicals industry's average of 5.83. The company's beta value is 0.94. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.